Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Sevoflurane Represses Proliferation and Migration of Glioma Cells by Regulating the ANRIL/let-7b-5p Axis.

  • Authors : Gao Y; Department of Anesthesiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.; Department of Anesthesiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Glioma*/Glioma*/Glioma*/drug therapy ; Glioma*/Glioma*/Glioma*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Mar; Vol. 39 (2), pp. 117-124. Date of Electronic Publication: 2020 Aug 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Sevoflurane Suppresses Glioma Cell Proliferation, Migration, and Invasion Both In Vitro and In Vivo Partially Via Regulating KCNQ1OT1/miR-146b-5p/STC1 Axis.

  • Authors : Wen J; Department of Anesthesiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.; Ding Y

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; Glioma*/Glioma*/Glioma*/drug therapy ; Glioma*/Glioma*/Glioma*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Mar; Vol. 39 (2), pp. 105-116. Date of Electronic Publication: 2020 Sep 30.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the PI3K / AKT Pathway.

  • Authors : Wang D; Department of Neurosurgery, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, People's Republic of China.; Wang Z

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Glioma*/Glioma*/Glioma*/genetics; Humans

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Mar; Vol. 39 (2), pp. 125-132. Date of Electronic Publication: 2021 Jan 20.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Metabolomic Profiles of Human Glioma Inform Patient Survival.

  • Authors : Scott AJ; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Department of Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.

Subjects: Glioma*/Glioma*/Glioma*/genetics ; Glioma*/Glioma*/Glioma*/metabolism ; Astrocytoma*/Astrocytoma*/Astrocytoma*/genetics

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Nov; Vol. 39 (13-15), pp. 942-956. Date of Electronic Publication: 2023 Apr 27.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Characterization of Prognostic Apoptosis-Related Gene Signature to Evaluate Glioma Immune Microenvironment and Experimental Verification.

  • Authors : Yu H; Department of Neurosurgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.; Yu J

Subjects: Glioma*/Glioma*/Glioma*/genetics; Humans ; Prognosis

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2024 Jan; Vol. 28 (1), pp. 22-32.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
Academic Journal

Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing.

  • Authors : Verma A; Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, India.; Patel R

Subjects: Drug Repositioning*/Drug Repositioning*/Drug Repositioning*/methods ; Glioma*/Glioma*/Glioma*/drug therapy ; Indazoles*

  • Source: Omics : a journal of integrative biology [OMICS] 2024 Feb; Vol. 28 (2), pp. 59-75. Date of Electronic Publication: 2024 Feb 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print-Electronic

Record details

×
Academic Journal

Exosome-Mediated Transfer of circ- GLIS3 Enhances Temozolomide Resistance in Glioma Cells Through the miR-548m/MED31 Axis.

  • Authors : Li G; Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Lan Q

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Feb; Vol. 38 (1), pp. 62-73. Date of Electronic Publication: 2021 Nov 11.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

High-Grade Gliomas from Subventricular Zone: Proteomic Drivers of Aggressiveness Using Fluorescence-Guided Multiple Sampling.

  • Authors : Ghantasala S; Centre for Research in Nano Technology and Science, Indian Institute of Technology Bombay, Powai, India.; Bhat A

Subjects: Glioma*/Glioma*/Glioma*/metabolism ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/metabolism; Humans

  • Source: Omics : a journal of integrative biology [OMICS] 2023 Dec; Vol. 27 (12), pp. 598-606. Date of Electronic Publication: 2023 Dec 07.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print-Electronic

Record details

×
Academic Journal

Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma.

  • Authors : Srivastava R; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; John G. Rangos Sr. Research Center, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioma*

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2023 Nov; Vol. 39 (13-15), pp. 904-922. Date of Electronic Publication: 2023 Jun 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Inhibitory Effects of Acetyloctadecadienediynoic Acid Isolated from Leaves of Dendropanax morbiferus on Viability and Self-Renewal Activity of Glioma Stem-Like Cells.

  • Authors : Kim HJ; Department of Animal Science and Chonnam National University, Gwangju, Korea.; Park YS

Subjects: Glioma*/Glioma*/Glioma*/drug therapy ; Glioblastoma*; Humans

  • Source: Journal of medicinal food [J Med Food] 2022 Oct; Vol. 25 (10), pp. 963-970.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9812512 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Improvement of Automatic Glioma Brain Tumor Detection Using Deep Convolutional Neural Networks.

  • Authors : Altameem A; Department of Computer Science and Engineering, College of Applied Studies and Community Services, King Saud University, Riyadh, Saudi Arabia.; Mallikarjuna B

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging ; Glioma*/Glioma*/Glioma*/diagnostic imaging; Algorithms

  • Source: Journal of computational biology : a journal of computational molecular cell biology [J Comput Biol] 2022 Jun; Vol. 29 (6), pp. 530-544. Date of Electronic Publication: 2022 Mar Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9433358 Publication Model: Print-Electronic

Record details

×
Academic Journal

miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4 .

  • Authors : Jiang H; Department of Hematology (Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Su Z

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

  • Source: Omics : a journal of integrative biology [OMICS] 2023 May; Vol. 27 (5), pp. 215-226.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print Cited

Record details

×
Academic Journal

Understanding Global Brain Network Alterations in Glioma Patients.

  • Authors : Derks J; Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Brain Tumor Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Subjects: Brain Neoplasms* ; Glioma*; Brain/Brain/Brain/diagnostic imaging

  • Source: Brain connectivity [Brain Connect] 2021 Dec; Vol. 11 (10), pp. 865-874. Date of Electronic Publication: 2021 Jun 17.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101550313 Publication Model: Print-Electronic

Record details

×
Academic Journal

[ 99m Tc]-Bis-Methionine-DTPA Single-Photon Emission Computed Tomography Impacting Glioma Management: A Sensitive Indicator for Postsurgical/Chemoradiotherapy Response Assessment.

  • Authors : Rani N; Department of Nuclear Medicine, PGIMER, Chandigarh, India.; Singh B

Subjects: Organotechnetium Compounds*; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*diagnostic imaging ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*therapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2021 Sep; Vol. 36 (7), pp. 568-578. Date of Electronic Publication: 2020 Jul 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Long Noncoding RNA TP53TG1 Contributes to Radioresistance of Glioma Cells Via miR-524-5p/RAB5A Axis.

  • Authors : Gao W; Department of Neurosurgery, Wuhan Puren Hospital, Wuhan, China.; Qiao M

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*radiotherapy ; Glioma/Glioma/Glioma/*radiotherapy ; MicroRNAs/MicroRNAs/MicroRNAs/*metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2021 Sep; Vol. 36 (7), pp. 600-612. Date of Electronic Publication: 2020 Aug 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ ZIC5 Axis in Glioma.

  • Authors : Han C; Department of Neurosurgery, The Sixth Medical Center of PLA General Hospital, Beijing, China.; Wang S

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*therapeutic use ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Exosomes/Exosomes/Exosomes/*metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2021 Sep; Vol. 36 (7), pp. 537-548. Date of Electronic Publication: 2020 Jul 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

MiR-24 Promotes Cell Growth in Human Glioma by CDX1 /PI3K/Akt Signaling Pathway.

  • Authors : Lei D; Department of Neurosurgery, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.; Sun H

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*metabolism ; Glioma/Glioma/Glioma/*metabolism ; Homeodomain Proteins/Homeodomain Proteins/Homeodomain Proteins/*metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2021 Sep; Vol. 36 (7), pp. 588-599. Date of Electronic Publication: 2020 Sep 01.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.

  • Authors : Yin H; Department of Drug Dispensing, The Second Hospital of Shandong University, Jinan, China.; Cui X

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Glioma/Glioma/Glioma/*drug therapy ; Kinesins/Kinesins/Kinesins/*metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2021 Sep; Vol. 36 (7), pp. 556-567. Date of Electronic Publication: 2020 Aug 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Rodent Brain Tumor Models for Studies Focusing on Boron Neutron Capture Therapy.

  • Authors : Barth RF; Department of Pathology, The Ohio State University, Columbus, Ohio, USA.; Carpenter DE

Subjects: Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/methods ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/pathology ; Glioma*/Glioma*/Glioma*/radiotherapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Apr; Vol. 38 (3), pp. 148-151. Date of Electronic Publication: 2022 Sep 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.

  • Authors : Porra L; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Wendland L

Subjects: Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/methods ; Glioma*/Glioma*/Glioma*/drug therapy ; Head and Neck Neoplasms*/Head and Neck Neoplasms*/Head and Neck Neoplasms*/drug therapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Apr; Vol. 38 (3), pp. 184-191. Date of Electronic Publication: 2022 Oct 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Strategies for Preclinical Studies Evaluating the Biological Effects of an Accelerator-Based Boron Neutron Capture Therapy System.

  • Authors : Kondo N; Particle Radiation Oncology Center, Institute for Integrated Radiation and Nuclear Science, Kyoto University, Asashiro-Nishi, Osaka, Japan.; Masutani M

Subjects: Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/methods ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/radiotherapy ; Glioma*

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Apr; Vol. 38 (3), pp. 173-183. Date of Electronic Publication: 2022 Sep 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy.

  • Authors : Perico D; Institute for Biomedical Technologies, National Research Council (ITB-CNR), Segrate, Italy.; Di Silvestre D

Subjects: Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/methods ; Glioma*/Glioma*/Glioma*/drug therapy; Humans

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Apr; Vol. 38 (3), pp. 152-159. Date of Electronic Publication: 2022 Oct 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Novel Post-Translational Modifications and Molecular Substrates in Glioma Identified by Bioinformatics.

  • Authors : Rex DAB; Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.; Arun Kumar ST

Subjects: Glioma*/Glioma*/Glioma*/genetics ; Proteomics*; Computational Biology

  • Source: Omics : a journal of integrative biology [OMICS] 2021 Jul; Vol. 25 (7), pp. 463-473. Date of Electronic Publication: 2021 Jul 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101131135 Publication Model: Print-Electronic

Record details

×
Academic Journal

Heterogeneous Glioma Cell Invasion Under Interstitial Flow Depending on Their Differentiation Status.

  • Authors : Namba N; Department of System Design Engineering, Keio University, Yokohama, Japan.; Chonan Y

Subjects: Brain Neoplasms* ; Glioblastoma* ; Glioma*

  • Source: Tissue engineering. Part A [Tissue Eng Part A] 2021 Apr; Vol. 27 (7-8), pp. 467-478. Date of Electronic Publication: 2021 Feb 15.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101466659 Publication Model: Print-Electronic

Record details

×
Academic Journal

Characterizing Distress and Identifying Modifiable Intervention Targets for Family Caregivers of Patients with Malignant Gliomas.

  • Authors : Forst DA; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.

Subjects: Caregivers*/Caregivers*/Caregivers*/psychology ; Glioma*; Humans

  • Source: Journal of palliative medicine [J Palliat Med] 2023 Jan; Vol. 26 (1), pp. 17-27. Date of Electronic Publication: 2022 Jun 16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9808462 Publication Model: Print-Electronic

Record details

×
  • 1-25 of  171 results for ""Glioma""